Enjoy complimentary customisation on priority with our Enterprise License!
The immunoprotein diagnostic market share is expected to increase by USD 11.48 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 8.64%.
This immunoprotein diagnostic market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers immunoprotein diagnostic market segmentations by application (oncology and endocrinology testing, infectious disease testing, autoimmune testing, and allergy testing), end-user (hospitals and clinics and diagnostic laboratories), and geography (North America, Europe, Asia, and ROW). The immunoprotein diagnostic market report also offers information on several market vendors, including Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens AG, Sofina SA, The Carlyle Group Inc., and Thermo Fisher Scientific Inc. among others.
Download the Free Report Sample to Unlock the Immunoprotein Diagnostic Market Size for the Forecast Period and Other Important Statistics
Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The increasing prevalence of infectious diseases is notably driving the immunoprotein diagnostic market growth, although factors such as high cost of products may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the immunoprotein diagnostic industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Immunoprotein Diagnostic Market Driver
The increasing prevalence of infectious diseases is one of the key factors driving the growth of the global immunoprotein diagnostic testing market. The incidences of COVID-19 have increased significantly across the world. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mainly responsible for COVID-19 infection. The outbreak of the COVID-19 pandemic in 2020 has affected several countries. For instance, according to the data published by the CDC, in the US, the total number of people reported with COVID-19 increased from 33,404 on March 23, 2020, to 39 million on September 01, 2021. Similarly, the Public Health England (PHE) stated that the number of confirmed cases of COVID-19 reported in the UK increased from 29,474 on April 1, 2020, to 6.8 million on September 01, 2021. The rising number of such infectious diseases is driving the demand for advanced diagnostic procedures to provide effective treatment to patients and thereby reduce the mortality rate due to infectious diseases. This, in turn, is boosting the growth of the global immunoprotein diagnostic testing market during the forecast period.
Key Immunoprotein Diagnostic Market Trend
The growing focus on next-generation products will fuel the global immunoprotein diagnostic testing market growth. Technological advances in immunoprotein diagnostics testing products will increase their adoption. The use of multiple assays for the detection of antigens and antibodies will increase the need for the screening of the diseases. Therefore, companies are focusing on developing advanced assays for immunoprotein diagnostic testing. For instance, Aushon BioSystems offers Ciraplex ULTRA Ultrasensitive Human 3-Plex IL-1?, IL-6, IL-10 Multiplexed Assay, which combines the ultrasensitive detection of immunoproteins with multiplexing to diagnose and treat diseases. The product can obtain low levels of detection of proteins for up to 3 biomarkers in one assay. Similarly, Merck KGaA (Merck) launched the MILLIPLEX MAP Human High Sensitivity cytokine panel, which was designed for use with the Luminex FLEXMAP 3D platform. The assay is fast, cost-effective, and generates results four times higher when compared with traditional assays using a smaller sample size. Such factors will increase the market growth during the forecast period.
Key Immunoprotein Diagnostic Market Challenge
The limited capability and high complexity of the procedure is a major challenge for the global immunoprotein diagnostic testing market growth. Immunoassays can only measure the concentration of an antigen. For infectious diseases, they can measure a specific bacterium or viral antigen. These assays may fail to detect the mutations of the original pathogens and the components cross-reacting with the antibodies or antigen-positive dead cells. Hence, they may provide false-positive results. Enzyme-linked immunosorbent assay (ELISA) is the gold standard diagnostic test for HIV. However, it requires monoclonal antibodies (mAb), which are expensive and difficult to obtain; a specialized instrument reader, and a washer, which may provide results that are not absolute or can detect only a specific antigen. Hence, the limited capability of the procedure could affect the growth of the market during the forecast period
This immunoprotein diagnostic market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Technavio categorizes the global immunoprotein diagnostic testing market as a part of the global life sciences tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the immunoprotein diagnostic market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the immunoprotein diagnostic market encompasses successful business strategies deployed by the key vendors. The immunoprotein diagnostic market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The immunoprotein diagnostic market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the immunoprotein diagnostic market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the global life sciences tools and services market includes the following core components:
The report has further elucidated on other innovative approaches being followed by service providers to ensure a sustainable market presence.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Application
6 Market Segmentation by End-user
7 Customer landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.